Disease-free survival and the prognostic factors affecting disease-free survival in patients with medullary thyroid carcinoma: a multicenter cohort study.
Sayid Shafi ZuhurBeyza Olcay OzturkUmran KeskinSerhat UysalAysa HaciogluUgur AvciSeda KarsliBurak AndacUmit Nur OzbayFaruk KilincSelvinaz ErolMerve CatakHulyanur SodanZafer PekkolaySebnem BurhanGulhan AkbabaCoskun AtesGoknur YorulmazSakin TekinBirol TopcuMazhar Muslum TunaPinar KadiogluMustafa Sait GonenZuleyha KaracaSema CiftciMehmet CelikSibel GuldikenDilek TuzunYuksel AltuntasMujde AkturkMutlu NiyazogluNese CinarOzen Oz GulMedine Nur KebapciAysen AkalinTaner BayraktarogluGulsah ElbukenPublished in: Endocrine (2024)
The absence of an excellent response after initial therapy is the strongest predictor of a worse DFS. However, a significant proportion of patients who achieve an excellent response could experience a structural recurrence. Therefore, careful follow-up of patients, including those achieving an excellent response is essential.